AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional ...
Zacks Investment Research on MSN
Down 24% in 4 weeks, here's why Nuvation Bio (NUVB) looks ripe for a turnaround
Nuvation Bio Inc. (NUVB) has been beaten down lately with too much selling pressure. While the stock has lost 24.1% over the ...
Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding ...
Intelligent Bio Solutions stock rises after announcing a manufacturing partnership targeting over 40% cost savings, major ...
The medical biotechnology company built a 100,000-square-foot lab near the airport to receive, treat and send blood cancer ...
Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveraging its first-in-class Flare ...
The collaboration will leverage Abalone Bio’s Functional Antibody Selection Technology platform for an undisclosed ...
Instil Bio said its subsidiary has discontinued clinical development of AXN-2510 and terminated its collaboration agreement with ImmuneOnco Biopharmaceuticals (Shanghai) for AXN-2510 and AXN-27M.
Jan 6 () - Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence ...
Learn how spectroscopy facilitates non-invasive, real-time bio-monitoring, enhancing decision-making in healthcare, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback